These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: The design of original antimalarial drugs. An example of phospholipid metabolism. Author: Vial HJ, Ancelin ML, Elabbadi N, Gumila C, Bonnet H, Jeong YH, Philippot J, Calas M, Portefaix P, Piquet G. Journal: Parassitologia; 1993 Jul; 35 Suppl():125-7. PubMed ID: 8233602. Abstract: The aim of our program was to find an original chemotherapeutical treatment (and eventually a preventive treatment) of malaria, an illness largely predominant in developing countries, by interfering on an essential metabolism developed by Plasmodium during its erythrocytic phase. Apart from what has been learnt about metabolism and the pharmacological target, a crucial step has been taken during this contract by passing from micromolar in vitro active concentrations (during 1986-1990) to nanomolar ones (during 1990). These compounds should naturally short-circuit resistance phenomena already established against drugs in current use, as has already been verified on polypharmacoresistant strains or isolates of P. falciparum. The administration of a therapeutic dose of our molecules would now appear to be possible in all cases.[Abstract] [Full Text] [Related] [New Search]